• LAST PRICE
    2.1400
  • TODAY'S CHANGE (%)
    Trending Down-0.0600 (-2.7273%)
  • Bid / Lots
    2.1500/ 1
  • Ask / Lots
    2.2200/ 1
  • Open / Previous Close
    2.2000 / 2.2000
  • Day Range
    Low 2.1300
    High 2.2150
  • 52 Week Range
    Low 1.9400
    High 7.5499
  • Volume
    73,513
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 2.2
TimeVolumeAPVO
09:32 ET6382.2
09:33 ET3882.205
09:35 ET12372.2
09:42 ET15672.17
09:46 ET1002.17
09:55 ET28002.17
09:57 ET38252.15
10:00 ET12802.16
10:04 ET1002.16
10:13 ET2002.16
10:20 ET5002.16
10:26 ET1202.16
10:27 ET9002.17
10:36 ET1002.19
10:49 ET12002.185
10:56 ET62522.2
10:58 ET4002.2
11:03 ET2902.2
11:12 ET14002.18
11:14 ET10002.1897
11:30 ET1152.1903
11:32 ET2142.2
11:54 ET40592.2
12:10 ET32002.2
12:12 ET2002.2
12:14 ET1002.2
12:15 ET12002.19
12:28 ET11002.19
12:30 ET1002.19
12:33 ET7002.2
12:35 ET8002.2
12:37 ET11002.2
12:42 ET16002.2
12:44 ET1002.2043
12:46 ET2002.2
12:57 ET25002.2
01:00 ET6952.2
01:02 ET29482.16
01:04 ET2002.16
01:31 ET11002.15
01:40 ET21842.15
01:42 ET8002.13
02:00 ET3002.14
02:02 ET1002.1427
02:05 ET1002.1443
02:09 ET12422.15
02:16 ET7102.14
02:27 ET5002.15
02:39 ET1002.15
02:41 ET2002.15
02:45 ET2002.15
02:48 ET11002.14
02:54 ET2882.14
03:12 ET2002.14
03:14 ET2852.1368
03:28 ET8402.13
03:33 ET2002.15
03:39 ET3442.15
03:48 ET2002.1509
03:50 ET4002.1501
03:57 ET16002.15
04:00 ET24932.14
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesAPVO
Aptevo Therapeutics Inc
10.9M
2.0x
---
United StatesTOMDF
Todos Medical Ltd
9.6M
-0.2x
---
United StatesMCUJF
Medicure Inc
9.6M
4.6x
---
United StatesGTH
Genetron Holdings Ltd
107.8M
-1.1x
---
United StatesPTE
PolarityTE Inc
5.7M
-0.2x
---
United StatesPHASQ
PhaseBio Pharmaceuticals Inc
797.7K
0.0x
---
As of 2023-02-04

Company Information

Aptevo Therapeutics Inc. is a clinical-stage, research and development biotechnology company. The Company is focused on developing immunotherapeutic candidates for the treatment of different forms of cancer. It has developed two platform technologies, such as ADAPTIR and ADAPTIR-FLEX for rational design of precision immune modulatory drugs. Its lead clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, are developed using its ADAPTIR modular protein technology platform. Its preclinical candidate APVO442 is being developed using its ADAPTIR-FLEX modular protein technology platform. APVO436 is a bispecific CD3xCD123 ADAPTIR that is designed to engage CD3 and CD123 to redirect T-cells to destroy leukemia cells expressing the target CD123 molecule on their surface. APVO603 is a preclinical dual agonist bispecific ADAPTIR candidate employing a mechanism of action to simultaneously target 4-1BB (CD137) and OX40 (CD134), both members of the TNF-receptor family.

Contact Information

Headquarters
2401 4th Ave Ste 1050SEATTLE, WA, United States 98121-3460
Phone
206-838-0500
Fax
206-838-0503

Executives

Independent Chairman of the Board
John Niederhuber
President, Chief Executive Officer, Director
Marvin White
Chief Financial Officer, Executive Vice President
Jeffrey Lamothe
Senior Vice President, General Counsel, Corporate Affairs and Human Resources
So Young Kwon
Independent Director
Daniel Abdun-Nabi

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$10.9M
Revenue (TTM)
$6.8M
Shares Outstanding
5.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
5.31
EPS
$1.07
Book Value
$0.25
P/E Ratio
2.0x
Price/Sales (TTM)
1.6
Price/Cash Flow (TTM)
1.7x
Operating Margin
179.75%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.